FORWARD LOOKING AND CAUTIONARY STATEMENTS
Some of the statements and information contained in this Quarterly Report on
Form 10-Q may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements regarding the
Company's financial position, business strategy and plans and objectives of the
Company's management for future operations and other statements that are not
historical facts, are forward-looking statements. Forward-looking statements are
often characterized by the use of words such as "outlook," "may," "will," "can,"
"shall," "should," "could," "expects," "plans," "anticipates," "contemplates,"
"proposes," "believes," "estimates," "predicts," "projects," "potential,"
"continue," "intend," or the negative of such terms and other comparable
terminology, or by discussions of strategy, plans or intentions.
Forward-looking statements involve known and unknown risks, uncertainties,
assumptions, and other important factors that could cause the actual results,
performance or our achievements, or industry results, to differ materially from
historical results, any future results, or performance or achievements expressed
or implied by such forward-looking statements. Such risks, uncertainties and
factors include, but are not limited to the impacts of the COVID-19 pandemic on
our business, financial results and financial condition and that of our
customers, suppliers, and other counterparties; general economic and financial
conditions domestically and internationally; insufficient cash flows from
operating activities; our ability to attract and retain key employees; feedstock
and product prices; feedstock availability and our ability to access third party
transportation; competition; industry cycles; natural disasters or other severe
weather events (including the Texas freeze event), health epidemics and
pandemics (including the COVID-19 pandemic) and terrorist attacks; our ability
to consummate extraordinary transactions, including acquisitions and
dispositions, and realize the financial and strategic goals of such
transactions; technological developments and our ability to maintain, expand and
upgrade our facilities; regulatory changes; environmental matters; lawsuits;
outstanding debt and other financial and legal obligations (including having to
return the amounts borrowed under the PPP Loans or failing to qualify for
forgiveness of such loans, in whole or in part); difficulties in obtaining
additional financing on favorable conditions, or at all; local business risks in
foreign countries, including civil unrest and military or political conflict,
local regulatory and legal environments and foreign currency fluctuations; and
other risks detailed in our latest Annual Report on Form 10-K, including, but
not limited to, "Part I, Item 1A. Risk Factors" and "Part II, Item 7.
Management's Discussion and Analysis of Financial Condition and Results of
Operations" therein, under similar headings in this Quarterly Report on Form
10-Q and in our other filings with the Securities and Exchange Commission (the
"SEC"). Many of these risks and uncertainties are currently amplified by and
will continue to be amplified by, or in the future may be amplified by, the
COVID-19 pandemic and other natural disasters such as severe weather events
(including the Texas freeze event).
There may be other factors of which we are currently unaware or deem immaterial
that may cause our actual results to differ materially from the forward-looking
statements. In addition, to the extent any inconsistency or conflict exists
between the information included in this report and the information included in
our prior releases, reports and other filings with the SEC, the information
contained in this report updates and supersedes such information.
Forward-looking statements are based on current plans, estimates, assumptions
and projections, and, therefore, you should not place undue reliance on them.
Forward-looking statements speak only as of the date they are made, and we
undertake no obligation to update them in light of new information or future
events.
Overview
The following discussion and analysis of our financial results, as well as the
accompanying unaudited condensed consolidated financial statements and related
notes to consolidated financial statements to which they refer, are the
responsibility of our management. Our accounting and financial reporting fairly
reflect our business model which is based on the manufacturing and marketing of
specialty petrochemical products and waxes and providing custom manufacturing
services.
The discussion and analysis of financial condition and the results of operations
which appears below should be read in conjunction with "Part II, Item 7.
Management's Discussion and Analysis of Financial Condition and Results of
Operations" of our Annual Report on Form 10-K for the year ended December 31,
2020. These discussions of results reflect the continuing operations of the
Company unless otherwise noted.
Our preferred supplier position into the specialty petrochemicals market is
derived from the combination of our reputation as a reliable supplier
established over many years, the very high purity of our products, and a focused
approach to customer service. In specialty waxes, we are able to deliver to our
customers a product performance and price point that is unique to our market;
while the diversity of our custom processing assets and capabilities offers
solutions to our customers that we believe are uncommon along the U.S. Gulf
Coast.
                              Table of Contents
                                                     18


--------------------------------------------------------------------------------

Enabling our success in these businesses is a commitment to operational
excellence which establishes a culture that prioritizes the safety of our
employees and communities in which we operate, the integrity of our assets and
regulatory compliance. This commitment drives a change to an emphasis on
forward-looking, leading-indicators of our results and proactive steps to
continuously improve our performance. We bring the same commitment to excellence
to our commercial activities where we focus on the value proposition to our
customers while understanding opportunities to maximize our value capture
through service and product differentiation, supply chain and operating cost
efficiencies and diversified supply options. We believe our focus on execution,
meeting the needs of our customers, and growing our business while maintaining
prudent control of our costs, will significantly contribute to enhanced
shareholder value.
Review of First Quarter 2021 Results
We reported first quarter 2021 net loss from continuing operations of $4.4
million, down from net income from continuing operations of $5.9 million in the
first quarter of 2020. During February 2021, a prolonged duration of
sub-freezing temperatures and snow resulted in widespread utilities failures and
rolling blackouts across the State of Texas and the region. This caused
significant disruptions for our suppliers, customers and our own facilities. The
Texas freeze event ultimately resulted in higher utility, repair and maintenance
costs, as well as loss of sales at both facilities. Cost impacts of the Texas
freeze event are estimated to be approximately $1.9 million across the Company,
in addition to capital expenditures related to restoration of approximately $1.7
million. Sales volume of our Specialty Petrochemicals products decreased 12.9%
in the first quarter of 2021 as compared to the first quarter of 2020. In
addition, sales of Specialty Petrochemicals were also generally weaker compared
to the same period last year due to the COVID-19 pandemic. Specialty Waxes sales
revenue was up 1.6% compared to the first quarter 2020 due to wax feed supply
interruptions in the first quarter of 2020.
Adjusted EBITDA from continuing operations was $(0.5) million for the first
quarter of 2021, compared with Adjusted EBITDA from continuing operations of
$5.5 million in the first quarter of 2020. Adjusted EBITDA from continuing
operations decreased due to factors associated with the Texas freeze event in
first quarter 2021, as noted above, which increased costs for the Company and
our suppliers and also reduced demand for our products through its impact on our
customers and their facilities. The Company estimates the impact of the Texas
freeze event on Adjusted EBITDA in the first quarter of 2021 to be between $4.5
million and $5.0 million. Adjusted EBITDA from continuing operations is a
non-GAAP financial measure. See below for additional information about this
measure and a reconciliation to the most directly comparable GAAP financial
measure.
COVID-19 Pandemic
The continued global impact of COVID-19 has resulted in various emergency
measures to curb the spread of the virus. We continue to monitor the progression
of the COVID-19 pandemic on a daily basis. Our guiding principle is, and has
always been, the protection of our people and the communities in which we work,
as well as maintaining the overall integrity of our assets. While our essential
plant personnel remain on-site, many of our other employees continue to work
remotely and socially distanced when in our offices. We are continuing to follow
the orders and guidance of federal, state, and local governmental agencies, as
we maintain our own stringent protocols in an effort to mitigate the spread of
the virus and protect the health of our employees, customers, and suppliers as
well as the communities in which we work. As an organization, we adopted social
distancing behaviors early, executed the necessary changes to enable all
possible job duties to be performed remotely and rapidly identified and executed
the necessary adjustments to support optimal productivity for all remote
workers.
To date, our plants have continued to operate as normal with regard to COVID-19,
and our supply chain has generally remained intact, with adequate availability
of raw materials. Importantly, under the U.S. Department of Homeland
Security guidance issued on April 17, 2020 as updated through August 18, 2020,
as well as many related state and local governmental orders, chemical
manufacturing sites are considered essential critical infrastructure, and as
such, are not currently subject to closure in the locations where we operate.
Although there has been some disruption in global logistics channels, we have
not experienced significant delays in fulfillment of customer orders.
The COVID-19 pandemic continues to have an impact on our business, results of
operations, financial position and liquidity for the first quarter of 2021. In
comparison to the same period in 2020, in the first quarter we continued to see
reduced demand for our products and services which we attribute to the economic
slowdown caused by the COVID-19 pandemic as well as to the Texas freeze event in
February. This weakened demand may continue throughout 2021, and could spread
more broadly to our other end markets.
Our management will continue to actively monitor the impact of the global
pandemic on our business, results of operations, financial condition, liquidity,
suppliers, industry, investments, and workforce. We do not currently anticipate
any material impairments, with respect to intangible assets, long-lived assets,
or right of use assets, increases in allowances for credit
                              Table of Contents
                                                     19


--------------------------------------------------------------------------------

losses from our customers, restructuring charges, other expenses, or changes in
accounting judgments to have a material impact on our condensed consolidated
financial statements.
On March 27, 2020, the CARES Act was signed into law to address the economic
impact of the COVID-19 pandemic. On December 27, 2020, the Consolidated
Appropriations Act, 2021 was signed into law and includes further relief and
stimulus provisions to address economic concerns related to the COVID-19
pandemic. On March 11, 2021, the American Rescue Plan Act of 2021 was signed
into law and provides further economic relief and stimulus to deal with the
economic impact of the COVID-19 pandemic. We continue to monitor any effects
that may result from these Acts and other similar legislation or actions on our
Company.
Non-GAAP Financial Measures
We include in this Quarterly Report on Form 10-Q the non-GAAP financial measures
of EBITDA from continuing operations and Adjusted EBITDA from continuing
operations and provide reconciliations from our most directly comparable GAAP
financial measures to those measures.
We believe these financial measures provide users of our financial statements
with supplemental information that may be useful in evaluating our operating
performance. We also believe that such non-GAAP measures, when read in
conjunction with our operating results presented under GAAP, can be used to
better assess our performance from period to period and relative to performance
of other companies in our industry, without regard to financing methods,
historical cost basis or capital structure. These measures are not measures of
financial performance or liquidity under GAAP and should be considered in
addition to, and not as a substitute for, analysis of our results under GAAP.
We define EBITDA from continuing operations as net income (loss) from continuing
operations plus interest expense, income tax expense (benefit), depreciation and
amortization. We define Adjusted EBITDA from continuing operations as EBITDA
from continuing operations plus share-based compensation, plus restructuring and
severance expenses, plus impairment losses and plus or minus gains or losses on
disposal of assets.
The following table presents a reconciliation of net income (loss), our most
directly comparable GAAP financial performance measure for each of the periods
presented, to EBITDA from continuing operations and Adjusted EBITDA from
continuing operations.
                                                                         Three Months Ended
                                                                           March 31, 2021
                                           Specialty
                                        Petrochemicals            Specialty Waxes           Corporate            Consolidated
                                                                           (in thousands)
Net income (loss)                     $            205          $        

(1,954) $ (2,655) $ (4,404) Income from discontinued operations, net of tax

                                           -                         -                    -                      -
Income (loss) from continuing
operations                            $            205          $         (1,954)         $    (2,655)         $      (4,404)
Interest expense                                   302                         -                    -                    302
Income tax benefit                                (486)                        -                 (515)                (1,001)
Depreciation and amortization                      200                        23                    3                    226
Depreciation and amortization in cost
of sales                                         2,602                     1,452                    -                  4,054
EBITDA from continuing operations     $          2,823          $           (479)         $    (3,167)         $        (823)
Stock-based compensation                             -                         -                  571                    571
Gain on disposal of assets                        (254)                        -                    -                   (254)

Adjusted EBITDA from continuing
operations                            $          2,569          $           (479)         $    (2,596)         $        (506)


                              Table of Contents
                                                     20


--------------------------------------------------------------------------------


                                                                         Three Months Ended
                                                                           March 31, 2020
                                           Specialty
                                        Petrochemicals            Specialty Waxes           Corporate            Consolidated
                                                                           (in thousands)
Net income                            $          4,596          $          1,214          $     4,910          $      10,720
Income from discontinued operations,
net of tax                                           -                         -                4,857                  4,857
Income from continuing operations     $          4,596          $          1,214          $        53          $       5,863
Interest expense                                   915                         -                    1                    916
Income tax benefit                              (1,654)                   (1,456)              (2,543)                (5,653)
Depreciation and amortization                      186                        24                    6                    216
Depreciation and amortization in cost
of sales                                         2,431                     1,305                    -                  3,736

EBITDA from continuing operations $ 6,474 $ 1,087 $ (2,483) $ 5,078 Stock-based compensation

                             -                         -                  390                    390
(Gain) loss on disposal of assets                   (1)                       17                    -                     16

Adjusted EBITDA from continuing
operations                            $          6,473          $          

1,104 $ (2,093) $ 5,484




Liquidity and Capital Resources
Working Capital
Our approximate working capital days are summarized as follows:
                                                    March 31, 2021                December 31, 2020                  March 31, 2020
Days sales outstanding in accounts
receivable                                             42.8                            40.0                             41.6
Days sales outstanding in inventory                    19.4                            20.5                             12.3
Days sales outstanding in accounts
payable                                                27.3                            22.9                             14.8
Days of working capital                                34.8                            37.7                             39.1


Our days sales outstanding in accounts receivable at March 31, 2021 was 42.8
days compared to 40 days at December 31, 2020. The increase was driven by higher
selling prices during the first quarter of 2021. Our days sales outstanding in
inventory decreased by approximately 1.1 days from December 31, 2020, driven
primarily by lower production and the need to meet customer demands utilizing
existing inventory. Our days sales outstanding in accounts payable increased
primarily due to significant payables to our utilities suppliers driven by
sharply higher rates for utilities in February 2021 due to the Texas freeze
event. Since days of working capital is calculated using the above three
metrics, it decreased for the aforementioned reasons discussed.
Our cash balance at March 31, 2021 was $53.0 million.
The change in cash is summarized as follows:
                                           Three Months Ended
                                                March 31,
                                                   2021          2020
Net cash provided by (used in)           (thousands of dollars)
Operating activities                $       3,831          $  4,301
Investing activities                       (4,500)            8,098
Financing activities                       (1,969)           18,906
Increase (decrease) in cash         $      (2,638)         $ 31,305
Cash                                $      53,026          $ 37,450


                              Table of Contents
                                                     21


--------------------------------------------------------------------------------

Operating Activities
Cash provided by operating activities totaled $3.8 million for the first three
months of 2021, $0.5 million lower than the corresponding period in 2020. For
the first three months of 2021, net income decreased by approximately $15.1
million as compared to the corresponding period in 2020. Major non-cash items
affecting income in the first three months of 2021 included changes in
depreciation and amortization of $4.3 million, deferred taxes of $(0.9) million,
and stock-based compensation of $0.6 million. Major non-cash items affecting
income in the first three months of 2020 included changes in depreciation and
amortization of $4.0 million, deferred taxes of $10.4 million and stock-based
compensation of $0.4 million.
Additional factors leading to the decrease in cash provided by operating
activities included:
•Trade receivables increased approximately $0.6 million, primarily due to
increases in selling prices. We do not expect any collection issues at this
time.
•Inventories decreased approximately $1.2 million driven by planned reduction of
inventory due to the successful turnaround at SHR combined with maintenance of
customer demand through existing inventory during the Texas freeze event.
•Prepaid and other assets decreased $2.8 million primarily related to the
payment of our foreign tax liability and amortization of our prepaid insurance
for the quarter.
•Accounts payable and accrued liabilities increased $1.3 million primarily due
to significant payables to our utilities suppliers driven by sharply higher
rates for utilities in February 2021 due to the Texas freeze event.
Investing Activities
Cash used in investing activities during the first three months of 2021 was
approximately $4.5 million, representing a decrease of approximately $12.6
million from the corresponding period of 2020. The primary outflow of the funds
used in investing activities was additions and the rebuild and restoration of
property, plant and equipment of approximately $4.8 million offset by proceeds
from the sale of assets.
Financing Activities
Cash used in financing activities during the first three months of 2021 was
approximately $2.0 million versus cash provided by financing activities of $18.9
million during the corresponding period of 2020. In the first quarter of 2021,
we made a mandatory payment of $1.1 million on our Term Loan Facility and
repurchased shares of our common stock under our Share Repurchase Program.
During the first three months of 2020, we borrowed $20.0 million under the
Revolving Facility for working capital purposes, offset by a mandatory payment
on our Term Loan Facility.
Anticipated Cash Needs
As of March 31, 2021, we have approximately $53.0 million in cash, combined with
an available balance on our Revolving Facility of approximately $53 million. As
a result, we believe the Company is able to support its operating requirements
and capital expenditures through internally generated funds supplemented with
cash on our balance sheet and availability under our ARC Agreement.
Results of Operations
Comparison of Three Months Ended March 31, 2021 and 2020
                              Table of Contents
                                                     22


--------------------------------------------------------------------------------

Specialty Petrochemicals Segment


                                                    Three Months Ended March 31,
                                               2021           2020        Change      % Change
                                                       (thousands of dollars)
Product Sales                          $  44,658       $ 50,386       $ (5,728)       (11.4) %
Processing                                 1,254          1,244             10          0.8  %
Gross Revenue                          $  45,912       $ 51,630       $ (5,718)       (11.1) %

Volume of Sales (gallons)
Specialty Petrochemicals Products         17,201         19,741         (2,540)       (12.9) %
Prime Product Sales                       14,675         16,218         (1,543)        (9.5) %
By-product Sales                           2,526          3,523           (997)       (28.3) %

Cost of Sales                          $  42,869       $ 44,796         (1,927)        (4.3) %
Gross Margin                                 6.6  %        13.2  %                     (6.6) %
Total Operating Expense*                  20,357         16,740          3,617         21.6  %
Natural Gas Expense*                       2,976            927          2,049        221.0  %
Operating Labor Costs*                     3,348          4,005           (657)       (16.4) %
Transportation Costs*                      4,606          4,887           (281)        (5.7) %
General & Administrative Expense           3,074          2,776            298         10.7  %
Depreciation and Amortization**            2,802          2,617            185          7.1  %
Capital Expenditures                       3,567          1,601          1,966        122.8  %


* Included in cost of sales
**Includes $2,602 and $2,431 for 2021 and 2020, respectively, which is included
in operating expense
Gross Revenue
Gross Revenue for our Specialty Petrochemicals segment decreased for the first
quarter 2021 compared to the first quarter 2020 by 11.1%, primarily due to lower
sales volumes for prime products and by-products which were impacted by the
Texas freeze event in February 2021 as well as continued impact of the COVID-19
pandemic.
Product Sales
Specialty Petrochemicals segment product sales declined approximately 11.4% for
the first quarter 2021 compared to the first quarter 2020. Prime products sales
volume declined approximately 1.5 million gallons, or 9.5%, from the first
quarter 2020 due to the Texas freeze event which resulted in widespread
utilities failures and rolling blackouts across the state and region. This
caused significant disruptions for our suppliers, customers and our own
facilities. In addition, sales were also generally weaker compared to the same
period last year due to the continued impact of the COVID-19 pandemic.
By-product sales volumes in first quarter 2021 declined 28.3% compared to the
first quarter 2020. By-products are produced as a result of prime product
production and their margins are significantly lower than margins for our prime
products. Foreign sales volume decreased to 17.8% of total Specialty
Petrochemicals volume in the first quarter for 2021 compared to 22.8% in the
first quarter 2020. Foreign sales volume includes sales to Canadian oil sands
customers.
Processing
Processing revenues were $1.3 million in the first quarter 2021 compared to $1.2
million for the first quarter 2020.
Cost of Sales (includes but is not limited to raw materials and total operating
expense)
We use natural gasoline as feedstock, which is the heavier liquid remaining
after ethane, propane and butanes are removed from liquids produced by natural
gas wells. The material is a commodity product in the oil/petrochemical markets
and generally is readily available. The price of natural gasoline is highly
correlated with the price of crude oil. Our Advanced Reformer unit upgrades the
by-product stream produced as a result of prime product production. This upgrade
allows us to sell our by-products at higher prices than would be possible
without the Advanced Reformer unit.
Cost of sales declined by 4.3% for the first quarter 2021 compared to the first
quarter 2020. The decline in cost of sales compared to the same period last year
was driven by depressed sales volumes, offset by higher natural gas costs
associated
                              Table of Contents
                                                     23


--------------------------------------------------------------------------------

with the Texas freeze event. Benchmark Mont Belvieu natural gasoline feedstock
price increased by 42% from $0.93 per gallon in first quarter 2020 to $1.33 per
gallon in the first quarter 2021. Despite the increase in feedstock costs, our
margins for prime products were relatively flat in the first quarter of 2021
compared to first quarter of 2020. By-product margins were higher compared to
the first quarter of 2020. This was primarily due to higher component prices.
The gross margin percentage for the Specialty Petrochemicals segment decreased
from 13.2% for the first quarter of 2020 to 6.6% in the first quarter of 2021,
primarily because of increased operating costs.
Total Operating Expense (includes but is not limited to natural gas, operating
labor, depreciation and transportation)
Total Operating Expense increased $3.6 million, or 21.6%, for the first quarter
2021 compared to the same period in 2020, primarily due to higher natural gas
costs and repair and maintenance costs associated with the Texas freeze event.
Capital expenditures primarily relate to restoration costs associated with
freezing weather in February 2021.
Capital Expenditures
Capital expenditures in the first quarter 2021 were approximately $3.6 million
compared to $1.6 million in the first quarter of 2020. First quarter 2021
capital expenditures included approximately $0.8 million for rebuild and repair
of a distillation tower, approximately $0.6 million for restoration costs
associated with the damage to pipes and other plant equipment due to the Texas
freeze event and approximately $0.8 million of continued work on the GSPL pipe
line.
Specialty Waxes Segment
                                                                         

Three Months Ended March 31,


                                                           2021              2020            Change                % Change
                                                                            (thousands of dollars)
Product Sales                                      $   6,907          $  6,797          $    110                     1.6  %
Processing                                             1,766             3,640            (1,874)                  (51.5) %
Gross Revenue                                      $   8,673          $ 10,437          $ (1,764)                  (16.9) %

Volume of specialty wax sales (thousand
pounds)                                                8,826            10,174            (1,348)                  (13.2) %

Cost of Sales                                      $   9,321          $  9,193          $    128                     1.4  %
Gross Margin (Loss)                                     (7.5) %           11.9  %                                  (19.4) %
General & Administrative Expense                       1,235             1,483              (248)                  (16.7) %
Depreciation and Amortization*                         1,476             1,328               148                    11.1  %
Capital Expenditures                               $   1,214          $    316          $    898                   284.2  %


*Includes $1,452 and $1,524 for 2021 and 2020, respectively, which is included
in cost of sales
Product Sales
Product sales revenue for the Specialty Waxes segment increased by 1.6% for the
first quarter of 2021 compared to the first quarter of 2020 due to higher
selling prices. Specialty wax sales volume decreased nearly 1.3 million pounds
in the first quarter of 2021 compared to the first quarter of 2020. Despite
utilizing existing inventories, wax sales volumes in the first quarter of 2021
were depressed due to extended disruptions to feed supply and production
limitations at our Pasadena facility resulting from the Texas freeze event. Our
wax feed is based on certain by-products produced as a result of polyethylene
production at major polyethylene producers' facilities on the US Gulf Coast.
Processing
Processing revenues were $1.8 million for the first quarter 2021, a $1.9 million
decrease compared to the first quarter 2020, driven by lower demand resulting
from the Texas freeze event in February 2021 and the resulting impacts on our
customers.
Cost of sales
Cost of sales increased by 1.4%, or approximately $0.1 million, in the first
quarter 2021 compared to the first quarter 2020. A reduction in force was
completed in the first quarter of 2021 to improve the overall cost structure for
the Specialty Waxes segment.
                              Table of Contents
                                                     24


--------------------------------------------------------------------------------

Depreciation


Depreciation for the first quarter 2021 was $1.5 million, a $0.1 million
increase compared to the first quarter of 2020.
Capital Expenditures
Capital Expenditures were approximately $1.2 million in the first quarter 2021
compared to $0.3 million in the first quarter of 2020. Capital expenditures
primarily relate to restoration costs associated with the damage to pipes and
other plant equipment due to the Texas freeze event in February 2021.
Corporate Segment
                                                      Three Months Ended March 31,
                                                       2021         2020      Change      % Change
                                                  (thousands of dollars)
General & Administrative Expense      $     3,023              $ 2,415

$ 608 25.2 %




Corporate expenses increased $0.6 million in the first quarter of 2021 compared
to the first quarter of 2020 primarily due to increases in consulting and
insurance costs.
Investment in AMAK - Discontinued Operations
                                                           Three Months Ended March 31,
                                                             2021        2020      Change      % Change
                                                       (thousands of dollars)
   Equity in earnings (losses) of AMAK      $    -                   $ 

(532) $ 532 100.0 %




Equity in earnings (losses) of AMAK include amortization of the difference
between the Company's investment in AMAK and the Company's share of net assets
of AMAK.
We completed the sale of our ownership interest in AMAK during the third quarter
of 2020. See Note 5 for additional discussion.
Contractual Obligations
Our contractual obligations are summarized in Part II, Item 7. "Management's
Discussion and Analysis of Financial Condition and Results of Operations," in
our Annual Report on Form 10-K for the year ended December 31, 2020. There have
been no other material changes to the contractual obligation amounts disclosed
in our Annual Report on Form 10-K for the year ended December 31, 2020.
Critical Accounting Policies and Estimates
Critical accounting policies are more fully described in Note 2, "RECENT
ACCOUNTING PRONOUNCEMENTS" to the consolidated financial statements set forth in
our Annual Report on Form 10-K for the year ended December 31, 2020. The
preparation of consolidated financial statements in accordance with generally
accepted accounting principles requires management to make estimates,
assumptions and judgments that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of revenue
and expenses during the period reported. By their nature, these estimates,
assumptions and judgments are subject to an inherent degree of uncertainty. We
base our estimates, assumptions and judgments on historical experience, market
trends and other factors that are believed to be reasonable under the
circumstances. Estimates, assumptions and judgments are reviewed on an ongoing
basis and the effects of revisions are reflected in the consolidated financial
statements in the period they are determined to be necessary. Actual results may
differ from these estimates under different assumptions or conditions. Our
critical accounting policies and estimates have been discussed with the Audit
Committee of the Board of Directors and discussed in our Annual Report on Form
10-K for the year ended December 31, 2020. For the three months ended March 31,
2021, there were no significant changes to these policies.
Recent and New Accounting Standards
See Note 2 for a summary of recent accounting guidance.
                              Table of Contents
                                                     25


--------------------------------------------------------------------------------



Off Balance Sheet Arrangements
As of March 31, 2021, we do not have any off-balance sheet arrangements that
have, or are reasonably likely to have, a current or future effect on our
financial statements, revenues or expenses, results of operations, liquidity,
capital expenditures or capital resources that are material to investors.

© Edgar Online, source Glimpses